Clinical trial

Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE)

NCT04296175

Drugs and interventions used in this trial

7 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Epirubicin Normalized identity: epirubicinView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention CTX Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Paclitaxel Normalized identity: paclitaxelView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention ddEpirubicin Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention ddCTX Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Paclitaxel(with carbo) Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Carboplatin Normalized identity: carboplatinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE)

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2020-03-05

PhasePHASE3

Conditions

Triple-negative Breast Cancerverified · MONDO: triple-negative breast carcinoma

Interventions

EpirubicinDRUG · verified · RxNorm: epirubicin

CTXDRUG

PaclitaxelDRUG · verified · RxNorm: paclitaxel

ddEpirubicinDRUG

ddCTXDRUG

Paclitaxel(with carbo)DRUG

CarboplatinDRUG · verified · RxNorm: carboplatin

Sponsors & collaborators

Fudan Universitylead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04296175 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.